3 Things to Know About Bronchiectasis
The American Lung Association launched an initiative to support people living with bronchiectasis through patient and provider resources.
Tag: bronchiectasis
All
Latest
3 Things to Know About Bronchiectasis
The American Lung Association launched an initiative to support people living with bronchiectasis through patient and provider resources.
Read More
Fifth Annual World Bronchiectasis Day Set for July 1
Global organizations unite to raise awareness and improve care for more than 1 million people living with bronchiectasis.
Read More
Global Respiratory Societies Mark World Bronchiectasis Day 2026
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.
Read More
Comorbid Bronchiectasis + Diabetes Tied to Worse Outcomes
A large-scale international study found that comorbid bronchiectasis and diabetes is associated with higher mortality, increased hospitalizations, and more frequent exacerbations.
Read More
World Bronchiectasis Conference 2026 Highlights New Tools and Patient Resources
Experts and healthcare organizations gathered in Germany for the 9th World Bronchiectasis Conference to share updates on clinical care, research findings, and new digital resources.
Read More
DPP-1 Inhibitors Aim to Reduce Bronchiectasis Flare-Ups
A new class of drugs offers a disease-based approach to managing non-cystic fibrosis bronchiectasis by targeting airway inflammation.
Read More
Bronchiectasis + Chronic Rhinosinusitis Patients More Likely to Have P. aeruginosa in Mucus
Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Read More
TV Host Promotes Bronchiectasis Awareness
Insmed Inc has partnered with TV host Ty Pennington to launch “Suspect Bronchiectasis (Suspect BE),” an educational initiative aimed at increasing awareness and proper diagnosis of bronchiectasis.
Read More
ATS Launches Initiative to Improve Bronchiectasis Diagnosis
An ATS study will analyze electronic health records across seven academic medical systems to identify misdiagnosed bronchiectasis cases.
Read More
Pulmonary Rehab Awareness Week Advocates for Greater Access
Pulmonary rehabilitation helps improve breathing and quality of life, and comprehensive PR programs deliver physical and emotional benefits for respiratory patients.
Read More
European Commission Approves Brinsupri for Non-CF Bronchiectasis
Brinsupri (brensocatib) is now the first and only authorized treatment for non-cystic fibrosis bronchiectasis in the EU for patients 12 and older with recurrent exacerbations.
Read More
COPD, Bronchiectasis, NTM Lung Disease Affect Men, Women Differently
Men and women with COPD reported differences in symptoms, mental health, disease burden, and other outcomes.
Read More
25 Centers Join Bronchiectasis and NTM Care Center Network
The Bronchiectasis and NTM Association has accepted eight Care Center and 17 Clinical Associate Center sites in 14 states into the Bronchiectasis and NTM Care Center Network (CCN).
Read More
Brensocatib Reduced Bronchiectasis Exacerbations, Improved Symptoms in Asian Patients
The phase 3 ASPEN trial revealed brensocatib 10 mg and 25 mg significantly reduced bronchiectasis exacerbations, prolonged time to first exacerbation, and improved quality-of-life scores.
Read More
Bronchiectasis and NTM Research Registry Data Presented at ERS 2025
The European Respiratory Society Congress featured two abstracts using data from the Bronchiectasis and NTM Research Registry.
Read More
FDA Approves Brensocatib (Brinsupri) for Non-Cystic Fibrosis Bronchiectasis
Insmed’s Brinsupri (brensocatib) has been approved by the FDA as an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years and older.
Read More
World Bronchiectasis Conference Features Data from Bronchiectasis/NTM Registry
Four abstracts using Bronchiectasis and NTM Research Registry data were presented at the World Bronchiectasis Conference, held in Brisbane, Australia.
Read More
Bronchiectasis and NTM Research Registry Data Presented at World Bronchiectasis Conference
Four abstracts using Bronchiectasis and NTM Research Registry data were presented at the World Bronchiectasis Conference, in Brisbane, Australia.
Read More
American Lung Association Launches New Campaign on World Bronchiectasis Day
On World Bronchiectasis Day, July 1st, the American Lung Association is launching a new campaign to support people living with bronchiectasis to improve their disease management, help connect them with emotional support and improve quality of life.
Read More
July 1: World Bronchiectasis Day Aims to Improve Early Detection
July 1, 2025 marks the fourth year of World Bronchiectasis Day, which was established in 2022 to raise awareness of bronchiectasis, a chronic lung disease with increasing prevalence globally.
Read More
25 Global Partners Unite for World Bronchiectasis Day
The Bronchiectasis and NTM Association joins 25 global patient advocacy organizations and professional societies to recognize the fourth annual World Bronchiectasis Day on July 1, 2025.
Read More
Products 2025: Secretion Clearance & Suction
A closer look at suction and secretion clearance devices from ABM Respiratory, Baxter, Neotech, Philips, Precision Medical, Sentec, Seoil Pacific, and Tactile Medical.
Read More
Home Care Study to Evaluate BiWaze Clear for Bronchiectasis
ABM Respiratory Care initiated a multicenter home care study to evaluate the impact of its BiWaze Clear System in patients living with bronchiectasis.
Read More
Bronchiectasis: Brensocatib Reduced Exacerbations, Slowed Lung Function Decline
Brensocatib significantly reduced the rate of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis compared to placebo.
Read More